Luce Boyer
Overview
Explore the profile of Luce Boyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brophy J, Dagenais G, Boyer L, Garcia-Labbe D, Bogaty P
Can J Cardiol
. 2019 Nov;
35(11):1505-1512.
PMID: 31679620
Background: High-sensitivity cardiac troponin T (hs-cTnT) is used to diagnosis acute myocardial infarction, often based on values exceeding the 99th percentile threshold (14 ng/L) of normal populations. The short- and...
2.
Cardinal H, Madore F, Brophy J, Joseph L, Hebert M, Min S, et al.
Int J Cardiol
. 2014 Apr;
173(3):603-7.
PMID: 24708933
No abstract available.
3.
Bogaty P, Dagenais G, Joseph L, Boyer L, Leblanc A, Belisle P, et al.
PLoS One
. 2013 Apr;
8(4):e60759.
PMID: 23579782
Background: C-reactive protein (CRP) is proposed as a screening test for predicting risk and guiding preventive approaches in coronary artery disease (CAD). However, the stability of repeated CRP measurements over...
4.
St Germaine C, Bogaty P, Boyer L, Hanley J, Engert J, Brophy J
Am J Cardiol
. 2010 Jun;
105(12):1740-5.
PMID: 20538124
The cardiovascular safety of cyclooxygenase-2-selective (coxibs) and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) is of concern, although most users remain free of adverse outcomes. A gene-drug interaction could modulate this cardiovascular...
5.
Cardinal H, Brophy J, Bogaty P, Joseph L, Hebert M, Boyer L, et al.
Am J Cardiol
. 2010 Mar;
105(6):797-803.
PMID: 20211322
Although both inflammation and apoptosis occur in acute coronary syndromes (ACSs), previous studies have not tested the diagnostic and prognostic utility of an approach that measures circulating markers of these...
6.
Cardinal H, Bogaty P, Madore F, Boyer L, Joseph L, Brophy J
Clin J Am Soc Nephrol
. 2009 Oct;
5(1):87-94.
PMID: 19875769
Background And Objectives: Prior reports have suggested that patients with impaired renal function receive less aggressive care after an acute coronary syndrome (ACS). The aim of this study was to...
7.
Bogaty P, Poirier P, Boyer L, Simard S, Morin J, Dagenais G
Am Heart J
. 2008 Oct;
156(4):790-6.
PMID: 18926162
Background: The aim of the study is to compare the impact of intravenous glucose versus lipid versus saline on exercise-induced myocardial ischemia in patients with stable angina. Methods: Twelve men...
8.
Bogaty P, Boyer L, Simard S, Dauwe F, Dupuis R, Verret B, et al.
J Am Coll Cardiol
. 2008 Jun;
51(24):2339-46.
PMID: 18549920
Objectives: This study was designed to prospectively determine, in patients with an acute coronary syndrome, whether the inflammatory marker, C-reactive protein (CRP), measured at hospital admission, discharge, and 1 month...
9.
Bogaty P, Brophy J, Boyer L, Simard S, Joseph L, Bertrand F, et al.
Arch Intern Med
. 2005 Jan;
165(2):221-6.
PMID: 15668370
Background: C-reactive protein (CRP), a marker of inflammation, is increasingly measured to stratify coronary artery disease risk and guide clinical management. However, little is known about how inflammatory markers fluctuate...
10.
Bogaty P, Brophy J, Noel M, Boyer L, Simard S, Bertrand F, et al.
Circulation
. 2004 Aug;
110(8):934-9.
PMID: 15302800
Background: The impact of cyclooxygenase (COX)-2 antagonist treatment on acute coronary risk is controversial. We investigated the effect of prolonged COX-2 inhibition on inflammatory profile and endothelial function in patients...